Infection in vitro, this protein was tested for clinical efficacy in HIV-1-infected individuals; however, no effect on plasma viral loads was observed [13]. Further examination revealed that doses of sCD4 that were significantly higher than those achieved in the clinical trial were required to neutralize primary clinical isolates of HIV-1, in contrast to the relatively sensitive, laboratory-adapte
64188 Web Directory
64188.org web directory is committed to maintain high standard of listings to ensure the success of the listed sites.
Latest Comments
Log in to comment or register here.